These findings suggest that S100A4, PRDX1, SLC7A7, and SLC7A11 may play important roles in modulating the overall immune infiltration in PAAD, while the significance of DIAPH3 in immune infiltration remains uncertain. The gene discussed is SLC7A11; the disease is pancreatic adenocarcinoma.